nirsevimab
nirsevimab noun: a human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants.
Noun
nirsevimab (uncountable)
- A human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants.
- There is another remedy under regulatory consideration, a monoclonal antibody shot developed by Sanofi and AstraZeneca, called nirsevimab. It is meant to be given at the hospital to babies who are born during the winter or in the fall, Jonathan Heinrichs, a Sanofi executive said in an interview.2023 May 18, Christina Jewett, “F.D.A. Panel Recommends R.S.V. Vaccine to Protect Young Infants”, in The New York Times
Origin of nirsevimab
From [Term?] + -vi- + -mab.
Questions about nirsevimab
- What does nirsevimab mean?
- Nirsevimab means a human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants.
- What part of speech is nirsevimab?
- Nirsevimab is a noun.
Words near nirsevimab in the dictionary
Source and license
Adapted from Wiktionary: nirsevimab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “nirsevimab.” Word.ws, https://word.ws/nirsevimab. Based on Wiktionary, CC BY-SA 4.0.
